Chemed (Chemed) Interest Expense

: $-3 Mil (TTM As of Dec. 2023)

View and export this data going back to 1982. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Chemed's interest expense for the three months ended in Dec. 2023 was $ -0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Chemed's Operating Income for the three months ended in Dec. 2023 was $ 108 Mil. Chemed's Interest Expense for the three months ended in Dec. 2023 was $ -0 Mil. Chemed's Interest Coverage for the quarter that ended in Dec. 2023 was 316.42. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Chemed Interest Expense Historical Data

The historical data trend for Chemed's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

-4.54

-2.36

-1.87

-4.58

-3.11

Chemed Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense																-1.60	-1.55	-0.77	-0.44	-0.34

Chemed Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3 Mil.

Chemed (NYSE:CHE) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Chemed's Interest Expense for the three months ended in Dec. 2023 was $-0 Mil. Its Operating Income for the three months ended in Dec. 2023 was $108 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $101 Mil.

Chemed's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	108.214	/	-0.342
	=	316.42

The higher the ratio, the stronger the company's financial strength is.

Chemed (Chemed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chemed Corp (NYSE:CHE) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

CXM:Germany

Address

255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726

Website

https://www.chemed.com

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.

Executives

Kevin J Mcnamara	director, officer: president & ceo	2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
Spencer S Lee	officer: vice president	2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
David Patrick Williams	officer: Vice President & CFO
Nicholas Michael Westfall	officer: Executive Vice President	8035 PEREGRINE LANE, CINCINNATI OH 45243
Patrick P Grace	director	1100 PARK AVE, APT 15C, NEW YORK NY 10128
Eileen P Mccarthy	director	3515 78TH STREET, #2, JACKSON HEIGHTS NY 11372
Michael D Witzeman	officer: vice president and controller	255 E 5TH STREET, SUITE 2600, CINCINNATI OH 45202
Mount John Meredith Jr.	director	2906 MABRY ROAD NE, ATLANTA GA 30319
Donald E Saunders	director	306 MIANI TRAIL, OXFORD OH 45056
Christopher J Heaney	director	101 S. FORT LAUDERDALE BEACH BLVD., APARTMENT 1602, FORT LAUDERDALE FL 33316
Ron Delyons	director	2692 MADISON ROAD, SUITE N1-313, CINCINNATI OH 45208
Naomi C Dallob	officer: VP and Chief Legal Officer	255 EAST FIFTH STREET, SUITE 2600, CINCINNATI OH 45202
Thomas C Hutton	director, officer: vice president	ONE ROCKEFELLER PLAZA, STE 1510, NEW YORK NY 10020
Walsh George J Iii	director	ONE CHASE MANHATTAN PLAZA, NEW YORK NY 10005
Andrea R Lindell	director